Please join the Coalition of State Rheumatology Organizations, the American
Autoimmune Related Diseases Association, the Global Healthy Living Foundation,
and the Arthritis Foundation, in cooperation with the Congressional Arthritis
Caucus, for a briefing on implementation of the Biologics Price Competition and
(Upper Nyack, NY) The Global Healthy Living Foundation, working with the Coalition of State Rheumatology Organizations (CRSO) and the Arthritis Foundation, in cooperation with the Congressional Arthritis Caucus, will co-host a congressional briefing to address the forthcoming availability of biosimilars in light of the U.S. Food and Drug Administration (FDA) not providing final guidance […]
Rheumatoid arthritis patient advocates for continued access to medication in North Dakota
The U.S. Food and Drug Administration is months away from approving the first biosimilar drugs, but a bill advanced by a legislative committee Monday would help Utah prepare for that day.
For patients who are uninsured or underinsured, new treatments on the cutting edge of medicine called biosimilars have the potential to expand access and save lives.